Research and Clinical Trials

Title  

COG AHEP0731: Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND# 122782, NSC# 683864) Added to High Risk Stratum Treatment

Brief Description  

This phase III trial is studying the side effects of giving doxorubicin hydrochloride together with combination chemotherapy and to compare different chemotherapy regimens to see how well they work in treating young patients with newly diagnosed liver cancer.

Who may be Eligible  

Please contact us for eligibility criteria.

Speciality/Disorder  

Liver

Status  

OPEN

Start Date  

07/26/2015

IRB Number  

AHEP0731

Principal Investigator  

Kaplan, Joel Adam

Contact Name  

Sceria Jenkins

For More Information, Contact  Sceria  , Jenkins
Phone:  980-442-2323 Fax:    
Email:  sceria.jenkins@atriumhealth.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204